Literature DB >> 10703493

Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.

D S Latchman1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10703493      PMCID： PMC1297431          DOI： 10.1177/014107689909201107

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  20 in total

1.  Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

Authors:  O Lindvall; P Brundin; H Widner; S Rehncrona; B Gustavii; R Frackowiak; K L Leenders; G Sawle; J C Rothwell; C D Marsden
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

2.  Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts.

Authors:  C Bencsics; S R Wachtel; S Milstien; K Hatakeyama; J B Becker; U J Kang
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

3.  Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors.

Authors:  R S Coffin; A R MacLean; D S Latchman; S M Brown
Journal:  Gene Ther       Date:  1996-10       Impact factor: 5.250

4.  A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons.

Authors:  A T Dobson; T P Margolis; F Sedarati; J G Stevens; L T Feldman
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

5.  Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa.

Authors:  L J Fisher; H A Jinnah; L C Kale; G A Higgins; F H Gage
Journal:  Neuron       Date:  1991-03       Impact factor: 17.173

6.  Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.

Authors:  P Horellou; E Vigne; M N Castel; P Barnéoud; P Colin; M Perricaudet; P Delaère; J Mallet
Journal:  Neuroreport       Date:  1994-12-30       Impact factor: 1.837

7.  Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence.

Authors:  A R MacLean; M ul-Fareed; L Robertson; J Harland; S M Brown
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

Review 8.  Gene transfer to neurons using herpes simplex virus-based vectors.

Authors:  D J Fink; N A DeLuca; W F Goins; J C Glorioso
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

9.  Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.

Authors:  M G Kaplitt; P Leone; R J Samulski; X Xiao; D W Pfaff; K L O'Malley; M J During
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

10.  Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase.

Authors:  M J During; J R Naegele; K L O'Malley; A I Geller
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728
View more
  1 in total

Review 1.  Gene therapy for brain tumors.

Authors:  K Bansal; H H Engelhard
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.